晨间信号Morning Signal
《科学》 第393卷 第6809期 · 2026年7月23日 · 中文解读

应变释放弹头实现可调共价抑制的后期官能团化

Late-stage functionalization with strain-release warheads enables tunable covalent inhibition · Z. P. Shultz et al.
约 52 分钟Research Article在小程序里点播,20 到 60 分钟做好
这篇讲什么
本文报道了一种模块化硫(IV)试剂平台,可在药物分子后期安装磺酰基和磺酰亚胺基双环丁烷基团,实现对半胱氨酸的选择性共价修饰,并展示了在临床前模型中的潜力。
原文开头
Full article and list of author affiliations: https://doi.org/10.1126/ science.adx7219 Zachary P. Shultz, Ansar Lee-Sam, Yun-Pu Chang, Luxin Sun, Dylan Grassie, Alessio Gabellini, Kyle Pedretty, Thomas Scattolin, Victoria Izumi, Bin Fang, Samer Sansil, Ramu Kakumanu, Lukasz Wojtas, John Koomen, Ernst Schönbrunn, Andrii Monastyrskyi, Derek Duckett, Justin M. Lopchuk* INTRODUCTION: Covalent drugs are transforming targeted therapy by forming durable bonds with disease-driving proteins, yet most rely on a narrow set of reactive groups, particularly acrylamides. These conventional approaches, although effective, can lead to off-target interactions and restrict broader application by their limited structural design. Expanding covalent drug design beyond these established chemotypes is essential to improve both selectivity and therapeutic performance. …
摘自《科学》(Science)第393卷 第6809期 · 2026年7月23日,Z. P. Shultz et al.。仅引用开头一小段供了解文章,版权归原刊所有,全文请阅读原刊。
晨间信号小程序码
微信扫码,在小程序里听完整版
不用登录先听一篇 · 或在微信搜索小程序 晨间信号
同期其他文章